FansUnite Entertainment Shortlisted as Finalist for 2021 SBC Rising Star Award

Category highlights achievement in innovation and software in the sports betting industry

FansUnite Entertainment Inc. (CSE: FANS) (OTCQX: FUNFF) ("FansUnite" or the "Company") is pleased to announce that it has been shortlisted for the SBC Awards 2021 'Rising Star In Sports Betting' category.

FansUnite was selected for its cutting-edge B2B iGaming technology and white label offerings that include an esports betting platform. The Company will compete against prominent brands, namely Bally's Corporation, Virgin Bet, Soft2Bet, Betmaster, and King J Entertainment in this category.

The eighth edition of the SBC Awards attracted a record number of entries across 43 categories. The winners will be announced on Tuesday, December 14, 2021 at the SBC Awards held at Evolution London.

"We are proud to be nominated for the 'Rising Star In Sports Betting' category at this year's SBC Awards alongside other well-established brands in the global gambling industry," said Scott Burton, CEO of FansUnite. "The nomination highlights our company's continued ascent in the gaming industry and we are pleased that our efforts to deliver a scalable, full sports and esports betting suite offering to operators across multiple regulated markets are being recognized."

"The shortlisting process for the SBC Awards 2021 has been the most difficult yet, thanks to the fantastic innovation, creativity, and leadership shown across the industry over the last 12 months," said SBC Managing Director Andrew McCarron in a news release. "The standard of the entries was uniformly high, so just making the cut for the shortlists is a real mark of excellence."

The full listing of companies nominated can be viewed here:
https://sbcevents.com/sbc-awards/#shortlists

About FansUnite Entertainment Inc.

FansUnite is a global sports and entertainment company, focusing on technology related to regulated and lawful online gaming and other related products. FansUnite has produced a one-of-a-kind complete iGaming platform, with a sports and esports focus geared for the next generation of online bettors and casino players. The platform includes products for pre-match betting, in-play betting, daily fantasy, content and a certified RNG to produce casino style chance games. The platform operates multiple B2C brands and B2B software for the online gambling industry. FansUnite also looks to acquire technology platforms and assets with high growth potential in new or developing markets. The Company also provides technological solutions and services in the global gaming and entertainment industries. Its technology includes fixed/parimutuel odds, in-stream betting, live betting, casino-style games, cryptocurrency wallet and news content.

For further information, please contact:

Prit Singh, Investor Relations at FansUnite
ir@fansunite.com
(905) 510-7636

Scott Burton, Chief Executive Officer of FansUnite
scott@fansunite.com

Darius Eghdami, President of FansUnite
darius@fansunite.com

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

FORWARD-LOOKING STATEMENTS: Certain information contained herein may constitute "forward-looking information" under Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "believes," "belief," "expects," "intends," "anticipates," "potential," "should," "may," "will," "plans," "continue" or similar expressions to be uncertain and forward-looking. Forward-looking statements may include, without limitation, statements relating to the efficacy of nominations; recognition from any potential awards at SBC Awards; FansUnite's ability to fulfill technology needs with its platform; business development plans of FansUnite; the Company's unique portfolio of assets; and discussion of future plans, projections, objectives, estimates and forecasts and the timing related thereto. Forward-looking statements are based on the Company's estimates and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of FansUnite to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Additional information regarding the risks and uncertainties relating to the Company's business are contained under the heading "Risk Factors" in the Company's Non-Offering Prospectus dated March 27, 2020 filed on its issuer profile on SEDAR at www.sedar.com and risks related to global pandemics, including the novel coronavirus (COVID-19) global health pandemic, and the spread of other viruses or pathogens and influence of macroeconomic developments. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The forward-looking statements in this news release are made as of the date of this release. FansUnite disclaims and does not undertake to update or revise any forward-looking statements or forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws.

Corporate Logo

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/99777

News Provided by Newsfile via QuoteMedia

FansUnite CSE:FANS Emerging Tech Investing

Sona Nanotech to Showcase Its THT Cancer Therapy at NCL 20th Anniversary Symposium and Provides Corporate Update

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that its Chief Scientific Officer, Dr. Len Pagliaro, has been invited to showcase Sona's developing Targeted Hyperthermia Therapy ("THT") cancer treatment today at the Nanotechnology Characterization Laboratory ("NCL"). Sona will be one of six commercial and academic collaborators to present its research at the NCL's 20th anniversary "Advancing Medical Applications of Cancer Nanotechnology" symposium. Sona's subsidiary was previously selected for the NCL Assay Cascade Program, the premier program in the World for bringing nanomaterials through critical preclinical stages and facilitating regulatory review, in which Sona's materials were assessed for biocompatibility. The NCL was established by the National Cancer Institute ("NCI") to accelerate the progress of nanomedicine by providing preclinical characterization and safety testing of nanoparticles. The NCL is a collaborative effort between NCI, the U.S. Food and Drug Administration ("FDA"), and the National Institute of Standards and Technology.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Sona Nanotech Issued Patent and Appoints New Board Member

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce the issuance of U.S. Patent No. 12117447 by the U.S. Patent and Trademark Office to the Company, entitled, "Metal Nanoparticles and Methods of Making Same". This patent covers the Company's proprietary process for manufacturing gold nanorods without the use of the toxic substance, cetyltrimethylammonium bromide ("CTAB"), which typically carries significant cytotoxic and genotoxic risks.

The Company is also pleased to announce the appointment of Mr. Wayne Myles, KC, FIIC, to its board of directors. An active investor and entrepreneur, Mr. Myles has served as lead counsel and strategic business advisor on more than 100 domestic and international acquisitions and sales, financings, government and regulatory affairs and licensing mandates. He has significant and diverse experience as a director of public and private companies. He also has been recognized with numerous professional achievements, distinctions and awards, including being named as one of "Canada's Top 25 Most Influential Lawyers' by Canadian Lawyer Magazine."

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

FansUnite Entertainment Shortlisted as Finalist for 2021 SBC Rising Star Award

In this article

What is satellite internet?

Does Starlink have an IPO date?

How can you get exposure before the Starlink IPO date?

Investor takeaway

In this article:

What is quantum computing?

How does quantum computing work?

What are the main uses of quantum computing?

How to invest in quantum computing companies

Major quantum computing stocks

Quantum computing startups

Investor takeaway

Latest News

Latest Press Releases

Related News

TOP STOCKS